Publication | Closed Access

Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and β1 integrin/FAK−mediated signalling

Tumor BiologyMedicineAcid Ceramidase InhibitionCancer Cell BiologyColorectal CancerCancer BiologyCellular BiochemistryRadiation OncologyOncologyCell BiologyCell SignalingCancer ResearchTransglutaminase 2